RCC
Clinical trials for RCC explained in plain language.
Never miss a new study
Get alerted when new RCC trials appear
Sign up with your email to follow new studies for RCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced kidney cancer: first human trial of NEO-811 begins
Disease control Recruiting nowThis early-stage study tests a new drug called NEO-811 in people with advanced clear cell kidney cancer that has spread or cannot be surgically removed. The goal is to find the safest dose and see how well the drug works. About 30 participants who have already tried other treatme…
Matched conditions: RCC
Phase: PHASE1 • Sponsor: Neomorph, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can a higher dose of cabozantinib outsmart advanced kidney cancer?
Disease control Recruiting nowThis phase 2 trial is testing whether a higher dose (80 mg) of the drug cabozantinib can help people with advanced kidney cancer whose disease has worsened while on the standard dose. About 18 participants will receive the higher dose daily. The main goal is to see how long the c…
Matched conditions: RCC
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests A2B395, a donor-derived CAR T-cell therapy designed to target cancer cells while sparing healthy ones. It is for adults with advanced solid tumors like colorectal, lung, or breast cancer that have lost a specific immune marker. The trial has two phases: first to …
Matched conditions: RCC
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Jun 26, 2026 14:35 UTC
-
Blood test may spot kidney cancer return before scans do
Knowledge-focused Recruiting nowThis study looks at whether a simple blood test that finds bits of tumor DNA can help doctors monitor kidney cancer after surgery. Researchers will follow 450 people who have just been diagnosed with kidney cancer and are having surgery to remove it. The goal is to see if the blo…
Matched conditions: RCC
Sponsor: Jinling Hospital, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC